Clinical Trial Update: Safety and Efficacy of Pucotenlimab in pLECC [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating the safety and efficacy of Pucotenlimab in lymphoepithelioma-like carcinoma; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoepithelioma
• Lymphoepithelioma-like Carcinoma

Drugs mentioned

• Pucotenlimab

Snippet

Sponsor: Sun Yat-sen University | Conditions: Lymphoepithelioma-like Carcinoma, Lymphoepithelioma | Phase 2 | Status: RECRUITING